Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (62.6), the stock would be worth ¥2.19 (74% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 242.6 | ¥8.49 |
0%
|
| 3-Year Average | 62.6 | ¥2.19 |
-74%
|
| 5-Year Average | 47.9 | ¥1.68 |
-80%
|
| Industry Average | 34.9 | ¥1.22 |
-86%
|
| Country Average | 28.8 | ¥1.01 |
-88%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
|
3.3B CNY | 242.6 | 80.2 | |
| ZA |
K
|
Kumba Iron Ore Ltd
JSE:KIO
|
99.5B ZAR | 5 | 6.8 | |
| BR |
|
Vale SA
BOVESPA:VALE3
|
365B BRL | 25.9 | 26.2 | |
| US |
|
Nucor Corp
NYSE:NUE
|
49.2B USD | -295.6 | 29.5 | |
| LU |
|
ArcelorMittal SA
AEX:MT
|
38.3B EUR | 103.6 | 13.7 | |
| AU |
|
Fortescue Metals Group Ltd
ASX:FMG
|
60.9B AUD | 11.2 | 11.2 | |
| AU |
F
|
Fortescue Ltd
XMUN:FVJ
|
37.2B EUR | 11.3 | 11.5 | |
| IN |
|
JSW Steel Ltd
NSE:JSWSTEEL
|
3.1T INR | 25.4 | 41.8 | |
| US |
|
Steel Dynamics Inc
NASDAQ:STLD
|
32.6B USD | 54.7 | 23.9 | |
| IN |
|
Tata Steel Ltd
NSE:TATASTEEL
|
2.7T INR | 20.7 | 29.2 | |
| KR |
|
Posco Holdings Inc
KRX:005490
|
31.6T KRW | -26.6 | 48 |
Market Distribution
| Min | 0 |
| 30th Percentile | 14.5 |
| Median | 28.8 |
| 70th Percentile | 57 |
| Max | 307 555.7 |
Other Multiples
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View
Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.
